[{"Assets_0_Q2_USD":55163000000.0,"EarningsPerShareDiluted_2_Q2_USD":1.92,"EarningsPerShareDiluted_1_Q2_USD":0.87,"EarningsPerShareBasic_2_Q2_USD":1.92,"EarningsPerShareBasic_1_Q2_USD":0.88,"StockholdersEquityConverted_0_Q2_USD":16151000000.0,"StockholdersEquity_0_Q2_USD":16049000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1635000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1636000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":1637000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":1637000000.0,"NetIncomeLossConverted_2_Q2_USD":3142000000.0,"NetIncomeLossConverted_1_Q2_USD":1432000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":3473000000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.41,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.41,"RevenuesConverted_1_Q2_USD":6273000000.0,"RevenuesConverted_2_Q2_USD":12193000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190725"}]